TMO
2nd
Thermo Fisher Scientific
$217,832.92 Mn
589.14
+0.61%
+20.84%
The Specialty Diagnostics segment manufactures and sells diagnostic test kits, reagents, and instruments for clinical diagnostics, immunodiagnostics, and transplant diagnostics to healthcare and clinical laboratories.
ABT
2nd
Abbott Laboratories
$194,996.90 Mn
112.69
+2.07%
-13.50%
The company provides diagnostic systems and tests, such as core lab systems, molecular diagnostics for HIV and SARS-CoV-2, and the BinaxNOW rapid tests.
DHR
2nd
Danaher
$140,348.04 Mn
199.67
-1.47%
-4.47%
The Diagnostics segment supplies clinical instruments and consumables for hematology, immunodiagnostics, and molecular testing used in hospitals and reference laboratories to diagnose disease.
ISRG
2nd
Intuitive Surgical
$138,438.60 Mn
391.18
+0.22%
-18.72%
The Ion endoluminal system is specifically used for minimally invasive lung biopsies, which is a clinical diagnostic application.
MDT
2nd
Medtronic
$117,891.52 Mn
92.09
+1.64%
-0.78%
The company develops and markets diagnostic equipment and monitoring solutions, such as insertable cardiac monitors, patient monitoring sensors, and continuous glucose monitoring systems.
BRKRP
2nd
Bruker
$64,020.24 Mn
420.21
-1.39%
—
The company provides clinical diagnostic solutions, including PCR-based molecular diagnostic tools and microbiology/infection diagnostics used by hospitals and clinical laboratories.
CAH
2nd
Cardinal Health
$54,655.30 Mn
235.00
-0.28%
+56.95%
The company operates nuclear pharmacies and manufacturing facilities that produce radiopharmaceuticals used for diagnostic imaging and theranostics in hospitals.
BDX
2nd
Becton Dickinson
$49,255.71 Mn
180.83
-0.71%
-7.27%
The Life Sciences segment provides clinical diagnostic equipment and tests, including automated blood culturing systems, molecular testing systems for infectious diseases, and rapid diagnostic assays.
MDLN
2nd
Medline
$44,845.83 Mn
34.12
-2.18%
—
Medline sells diagnostic equipment and consumables, specifically point-of-care testing, analyzers, instrumentation, and vital signs monitors through its Laboratory and Diagnostics category.
IDXX
2nd
Idexx Laboratories
$43,642.56 Mn
553.32
+1.32%
-13.25%
Idexx manufactures and sells clinical diagnostic equipment and tests, including point-of-care analyzers and water testing instrumentation like Colilert and Colisure for water utilities and government laboratories.
A
2nd
Agilent Technologies
$41,892.46 Mn
148.44
+0.00%
+25.64%
The company's Diagnostics and Genomics segment sells clinical diagnostic equipment and tests, specifically PCR systems, microarrays, and related reagents used by clinical diagnostics labs and hospitals.
GEHC
GE HealthCare Technologies
$32,805.97 Mn
72.63
+0.36%
-0.74%
The company's largest segments, Imaging and Advanced Visualization Solutions, focus on manufacturing clinical diagnostic equipment such as CT, MRI, X-ray, and Ultrasound systems. These products are sold to hospitals and health systems for the purpose of clinical diagnosis.
ILMN
2nd
Illumina
$28,431.79 Mn
188.29
-2.51%
+87.30%
The company sells integrated systems and consumables for clinical applications, including noninvasive prenatal testing and oncology, which are used by commercial molecular diagnostic laboratories for clinical diagnosis.
EXAS
2nd
Exact Sciences
$20,017.07 Mn
104.91
+0.95%
+136.92%
The company develops and commercializes the proprietary molecular and blood-based testing platforms and biomarker algorithms used to run its diagnostic tests. This includes the development of the Cologuard and Oncodetect platforms.
FTV
2nd
Fortive
$17,989.57 Mn
59.45
-1.95%
+24.50%
Fortive sells biomedical test equipment and tools through its Fluke Biomedical brand, which are used for clinical diagnostic and equipment testing in healthcare facilities.
COO
2nd
Cooper Companies
$14,765.62 Mn
75.76
+0.88%
+3.03%
The CooperSurgical segment generates revenue from fertility offerings that include diagnostics and genetic testing equipment used to support in vitro fertilization and assisted reproductive technologies.
BAX
2nd
Baxter International
$13,405.71 Mn
25.93
+0.04%
+9.83%
The Healthcare Systems & Technologies segment includes the sale of patient monitoring and diagnostic technologies used for clinical diagnosis.
RVTY
2nd
Revvity
$12,687.10 Mn
113.70
-2.10%
+26.77%
The Diagnostics segment manufactures and sells clinical diagnostic equipment and tests, such as prenatal screening kits, infectious disease testing platforms, and genomic workflow solutions based on PCR and next generation sequencing.
TECH
2nd
Bio-Techne
$11,303.59 Mn
72.22
-0.23%
+35.52%
The company's Diagnostics and Spatial Biology segment develops and sells diagnostic products including immunoassay kits, exosome-based liquid biopsy assays, and instrument systems for tissue biopsy and proteomic analysis for regulated clinical diagnostics markets.
BIO
2nd
Bio-Rad Laboratories
$8,876.13 Mn
352.16
-0.85%
+23.72%
The Clinical Diagnostics segment designs and manufactures diagnostic test systems, test kits, and specialized quality controls for in vitro diagnostics. These products are sold as integrated systems to hospital laboratories, diagnostic reference laboratories, and physician office laboratories.
GIFLF
2nd
Grifols
$8,002.83 Mn
11.76
+0.00%
-15.40%
The company has a dedicated Diagnostic segment that develops and sells in vitro diagnostic assays, nucleic acid testing platforms, and immunohematology analyzers for blood typing and infectious disease screening.
SATA
2nd
Strive
$7,940.31 Mn
99.69
+0.21%
—
Through its subsidiary Semler Scientific, the company markets the QuantaFlo FDA cleared vascular testing device, which is a sensor-based product used for in-office blood flow tests. Revenue is derived from licensing fees and service agreements tied to the volume of tests performed using this diagnostic equipment.
OKLO
2nd
Oklo
$7,659.03 Mn
41.38
-5.68%
-40.02%
Through its subsidiary Atomic Alchemy, the company produces and sells radioisotopes for medical research and other applications, which falls under the manufacture of clinical diagnostic and medical-grade isotopes.
LNTH
Lantheus Holdings
$6,543.47 Mn
100.26
-0.64%
+79.13%
Lantheus primarily generates revenue from the sale of diagnostic imaging agents such as PYLARIFY for prostate cancer PET imaging, DEFINITY for ultrasound enhancement, and Neuraceq for amyloid PET imaging. These products are sold to hospitals and independent imaging centers to facilitate clinical diagnosis.
RADX
2nd
Radiopharm Theranostics
$6,196.17 Mn
2.62
-1.87%
-49.42%
The company develops diagnostic radiotracers and imaging agents, such as RAD101 for brain metastases and RAD301 for PET imaging, which are clinical diagnostic tests sold as products.
STVN
2nd
Stevanato Group S.p.A
$5,788.27 Mn
21.20
-0.70%
-6.15%
The company provides diagnostic consumables and equipment to in vitro diagnostic firms.
MMED
2nd
MiniMed
$5,436.68 Mn
19.36
-0.87%
—
MiniMed develops and markets continuous glucose monitors (CGMs), which are clinical diagnostic platforms used for real-time glucose sensing and monitoring.
TLX
2nd
Telix Pharmaceuticals
$4,024.67 Mn
11.88
+1.28%
-0.17%
The company sells diagnostic imaging agents and platforms, such as Illuccix and Gozellix, which are used for prostate cancer imaging in clinical settings.
HTFL
Heartflow
$3,922.23 Mn
45.23
+7.84%
+50.92%
Heartflow sells a diagnostic test (FFR CT Analysis and Plaque Analysis) that uses AI and 3D modeling to diagnose coronary artery disease. The company generates revenue on a pay-per-click basis when physicians review these diagnostic analyses, fitting the model of selling a diagnostic test rather than performing the scan itself.
SXI
2nd
Standex International
$3,866.62 Mn
320.88
-1.68%
+57.34%
The Scientific segment manufactures medical-grade and laboratory temperature-controlled equipment, including ultra-low temperature freezers, blood bank refrigerators, and environmental stability chambers sold to healthcare facilities and laboratories.
MIR
2nd
Mirion Technologies
$3,726.85 Mn
15.32
-2.73%
-25.20%
The company sells nuclear medicine products for patient dosing and medical diagnostics, as well as radiation therapy quality assurance hardware and software used in cancer centers.
OSIS
2nd
Osi Systems
$3,605.23 Mn
218.73
-4.85%
-5.40%
The Healthcare segment provides diagnostic imaging systems, ultrasound systems, and fetal Doppler devices to hospitals and clinics, which are clinical diagnostic equipment and tests.
VCYT
2nd
Veracyte
$3,269.20 Mn
40.68
-3.33%
+35.28%
The company sells in vitro diagnostic (IVD) kits, such as Prosigna, to hospitals and laboratories outside the United States. This represents a product-based revenue stream where the customer buys the test kit to perform the analysis locally.
GRAL
2nd
Grail
$3,166.39 Mn
70.89
+1.34%
+116.13%
The company develops and commercializes the Galleri screening tool and methylation technology, which functions as a molecular point-of-care testing platform for cancer detection.
NEOG
Neogen
$2,518.79 Mn
11.57
-2.53%
+108.84%
Neogen's primary revenue driver is its Food Safety segment (71.3% of sales), which develops and markets diagnostic test kits for pathogen, toxin, and allergen detection, as well as culture media. These products are sold to food producers, processors, and regulatory agencies like the USDA and FDA for clinical and safety diagnostics.
CDNA
2nd
CareDx
$2,377.46 Mn
46.18
-0.43%
+289.70%
The company manufactures and sells diagnostic laboratory products and kits, including HLA typing kits like QTYPE and next-generation sequencing offerings like AlloSeq Tx, to hospitals and reference laboratories.
BFLY
Butterfly Network
$2,141.96 Mn
9.00
-0.22%
+525.00%
Butterfly Network manufactures and sells clinical diagnostic equipment, specifically handheld ultrasound devices like the Butterfly iQ3 and Butterfly iQ+, which are used for point-of-care imaging. Its revenue is driven by the sale of these diagnostic instruments and the associated AI-driven software and consumables.
ATEC
2nd
Alphatec Holdings
$1,472.30 Mn
9.53
+0.85%
-39.91%
The company generates revenue from the sale of imaging systems and associated software solutions used in the clinical setting for spine care.
NNNN
Anbio Biotechnology
$1,201.49 Mn
8.35
-1.53%
-83.84%
Anbio Biotechnology designs and sells in vitro diagnostic kits and instruments, including real-time PCR and chemiluminescence immunoassay products. Its revenue is derived from the sale of these diagnostic machines and the associated assays to hospitals, clinics, and laboratories.
CBLL
Ceribell
$925.38 Mn
24.21
-0.78%
+98.77%
Ceribell sells the Ceribell System, which includes the Clarity recorder device and AI-powered algorithms for the rapid diagnosis and continuous monitoring of seizures and delirium. These are clinical diagnostic tools sold to hospitals for point-of-care EEG testing, fitting the description of diagnostic equipment and assays.
QDEL
QuidelOrtho
$917.27 Mn
13.43
-7.89%
-47.99%
QuidelOrtho manufactures and sells clinical diagnostic equipment and tests, including the VITROS platform for clinical chemistry and the ORTHO VISION platform for immunohematology. Its revenue model is based on the sale of instruments and a recurring stream of assays, reagents, and consumables.
VREX
Varex Imaging
$778.05 Mn
18.46
+0.00%
+67.36%
Varex designs and manufactures X-ray tubes, flat panel and photon counting detectors, and image processing software used in computed tomography, mammography, and fluoroscopy. These products are sold to OEMs and end-users for clinical diagnostic radiology modalities.
CTKB
2nd
Cytek Biosciences
$607.02 Mn
4.67
-1.48%
+15.02%
The company sells its instruments and software to clinical laboratories for applications such as immunophenotyping and rare event analysis, which are used for clinical diagnostic purposes.
MLAB
2nd
Mesa Laboratories
$604.01 Mn
107.94
+0.28%
+57.81%
The company sells clinical diagnostic tools and consumables, such as the MassARRAY system and related reagent solutions, used by reference pathology labs and clinical research labs for inherited disease and oncology testing.
TKNO
2nd
Alpha Teknova
$365.58 Mn
6.81
-5.68%
+54.42%
The company's Clinical Solutions segment provides GMP-grade custom products used specifically in the development and production of diagnostic kits and in vitro diagnostics franchises.
CATX
2nd
Perspective Therapeutics
$365.08 Mn
3.20
-0.62%
-13.28%
The company develops and sells companion imaging agents using the isotope Lead 203 for patient selection and dosimetry, which are clinical diagnostic tools used to identify suitable patients for therapy.
PRE
Prenetics Global
$329.46 Mn
19.40
+0.15%
+155.94%
Prenetics operates ACT Genomics, which provides FDA-cleared comprehensive genomic profiling tests for solid tumors to hospitals and physicians. This activity involves selling diagnostic tests and the associated genomic profiling services for clinical use in oncology.
CV
CapsoVision
$307.70 Mn
6.15
-4.65%
+53.75%
CapsoVision manufactures and sells the CapsoCam capsule endoscopy system, which is a clinical diagnostic tool used to visualize and detect pathologies in the small bowel and colon. Revenue is generated from the sale of these diagnostic capsules and associated software platforms like CapsoCloud and CapsoView.
BCYC
2nd
Bicycle Therapeutics
$278.56 Mn
3.99
-0.25%
-47.08%
The company develops Bicycle imaging agents used to validate targets before therapeutic development, which falls under the category of diagnostic equipment and tests.
MYGN
2nd
Myriad Genetics
$274.37 Mn
2.87
-5.90%
-49.74%
The company develops and commercializes diagnostic assays and companion diagnostics, such as BRACAnalysis CDx and MyChoice CDx, which are sold as specific diagnostic products to laboratories and providers.
OSUR
Orasure Technologies
$263.97 Mn
3.75
-1.57%
+33.93%
The company's primary business is the development and manufacture of diagnostic products, including rapid point-of-care tests for HIV, hepatitis C, and COVID-19. It generates significant revenue from the sale of these diagnostic test kits and related instruments to hospitals, clinics, and public health organizations.
ACIU
2nd
AC Immune
$262.05 Mn
2.57
+1.58%
+19.53%
The company has a dedicated Diagnostics segment focused on developing positron emission tomography (PET) tracers, such as PI-2620 and ACI-12589, which are used as diagnostic imaging agents to detect protein aggregates in the brain.
RELL
2nd
Richardson Electronics
$239.30 Mn
19.01
-4.57%
+96.38%
The company manufactures, repairs, and distributes high-value replacement parts for diagnostic imaging, specifically CT and MRI tubes and RF amplifiers, sold to hospitals and medical centers.
ZSQR
2nd
Z Squared
$204.05 Mn
3.85
-0.26%
-73.72%
The company is developing the CD38-Diagnostic program, a diagnostic tool intended for healthcare providers to identify patients who would benefit from specific monoclonal antibody therapies.
LUCD
2nd
Lucid Diagnostics
$188.85 Mn
0.99
+1.02%
-2.94%
The company sells specimen kits and related consumables, including the EsoCheck Esophageal Cell Collection Device, to healthcare providers who collect samples on site.
IMDX
Insight Molecular Diagnostics
$139.63 Mn
4.28
+0.23%
+60.30%
The company develops and commercializes test kits, such as the GraftAssureIQ and GraftAssureDx IVD, which allow hospitals and laboratories to perform molecular diagnostic testing in-house. Its revenue model is based on the sale of these diagnostic kits and the associated reagents used on digital PCR instruments.
PAVM
PAVmed
$118.42 Mn
5.06
-4.89%
-60.87%
PAVmed's Lucid Diagnostics subsidiary sells the EsoGuard esophageal DNA test and the EsoCheck cell collection device to healthcare providers for the early detection of cancer. Revenue is generated from the sale of these diagnostic products and services, reimbursed by insurers and government programs.
SERA
2nd
Sera Prognostics
$97.42 Mn
1.93
-1.03%
-18.91%
The company develops and sells the PreTRM test and maintains a pipeline of biomarker candidates for conditions such as preeclampsia and gestational diabetes, which constitutes the sale of a diagnostic test product.
LUNG
2nd
Pulmonx
$94.18 Mn
2.26
+1.35%
+41.25%
The company sells the Chartis System and LungTraX Platform, which are described as patient assessment tools and software used for clinical diagnosis and treatment planning for severe emphysema.
ICCC
2nd
Immucell
$88.64 Mn
9.76
+0.62%
+59.74%
The company sells the California Mastitis Test, which is used for the on-farm detection of udder inflammation, fitting the description of clinical diagnostic tests and assays.
BNR
2nd
Burning Rock Biotech
$87.87 Mn
10.00
+9.89%
-1.67%
Through its In-Hospital Model, the company sells turnkey laboratory solutions and recurring reagent kits to hospitals, which constitutes the sale of diagnostic equipment and the consumables required to run them.
HYPR
Hyperfine
$81.89 Mn
0.90
+0.00%
-30.23%
Hyperfine manufactures and sells the Swoop® system, which is a portable ultra low field magnetic resonance brain imaging scanner used for clinical diagnosis. The company generates revenue from the sale of these diagnostic instruments and recurring software service and support agreements.
RTGN
RetinalGenix Technologies
$75.02 Mn
4.00
+0.00%
+12.99%
The company's core revenue strategy centers on the sale of DNA/GPS laboratory-developed genetic testing kits and the development of the RetinalCam imaging device for screening and monitoring eye health. These products are clinical diagnostic tools sold to patients and healthcare providers to identify biomarkers and disease states.
RPID
Rapid Micro Biosystems
$70.93 Mn
1.56
+0.65%
-41.13%
Rapid Micro Biosystems sells the Growth Direct platform, which is an automated microbial testing system using high-speed imaging and vision algorithms for clinical/quality control diagnosis. Revenue is generated from the sale of these diagnostic instruments and the proprietary consumables and reagents required to run them.
NNOX
Nano-X Imaging
$61.94 Mn
0.89
-4.30%
-79.11%
The company develops and sells the Nanox. ARC hardware system, which is a digital X-ray source used for medical imaging. Its primary business is the sale of this diagnostic equipment to hospitals, clinics, and imaging centers.
MDAI
Spectral AI
$51.82 Mn
1.61
-1.83%
-24.06%
Spectral AI develops the DeepView System, which is a clinical diagnostic platform combining multispectral imaging and AI algorithms to predict wound healing. The company sells both the imaging device (hardware) and the associated diagnostic software to hospitals and burn centers.
PRPO
2nd
Precipio
$43.97 Mn
24.69
+3.31%
+72.66%
The company's Products Division commercializes proprietary diagnostic assays and kits, such as HemeScreen and IV-Cell, which are sold as products to external clinical laboratories.
ARAY
2nd
Accuray
$36.87 Mn
0.31
-6.06%
-80.86%
The company's platforms provide integrated imaging that produces diagnostic quality CT images, and it sells software licenses for image guidance, which aligns with the manufacture of clinical diagnostic equipment and assays.
BEAT
2nd
HeartBeam
$27.05 Mn
0.48
-4.00%
-59.66%
The company sells cloud-based algorithms and a physician portal used to synthesize 12-Lead ECGs from 3D signals for advanced diagnostics. These software components and the associated hardware function as a clinical diagnostic platform for arrhythmia and ischemia detection.
QTEX
2nd
QTREX Quantum
$26.66 Mn
0.90
-4.26%
-27.71%
The company develops and plans to commercialize the HYLA blood sensor as a standalone monitor to provide continuous oxygen and carbon dioxide data, which functions as a clinical diagnostic testing platform.
QUCY
Quantum Cyber
$25.53 Mn
1.43
-2.72%
-20.56%
Mainz Biomed manufactures and sells the ColoAlert in vitro diagnostic test, which combines a fecal immunochemical test and PCR analysis, to clinical laboratories and hospitals. The company's revenue is generated through the sale of these diagnostic tests and associated consumables rather than performing the tests itself.
GIPL
2nd
Global Innovative Platforms
$24.34 Mn
0.50
+0.00%
+316.67%
The company manufactures clinical diagnostic equipment, specifically gas chromatographs and the FROG unit, and sells the associated consumables and reagents required to run these tests.
AIFF
Firefly Neuroscience
$22.43 Mn
1.09
-3.54%
-60.65%
Firefly Neuroscience manufactures and sells the FDA 510k cleared Evoke System, which is a diagnostic platform used to capture and analyze EEG and ERP assessments. The company generates revenue from subscriptions that provide clinics with this diagnostic equipment and the associated analytics and reporting platform.
ALLR
2nd
Allarity Therapeutics
$21.48 Mn
1.35
+0.75%
+48.35%
The company develops and sells the Drug Response Predictor (DRP®) platform, which creates cancer drug-specific companion diagnostics to identify patients likely to benefit from therapy. This platform has supported FDA Investigational Device Exemption (IDE) applications for stenoparib and Liposomal CisPlatin.
PLSM
Pulsenmore
$18.66 Mn
2.87
-0.69%
—
Pulsenmore designs and manufactures portable ultrasound devices, such as the Pulsenmore ES and FC, which are used for diagnostic imaging of fetal heartbeats and ovarian follicles. The company generates revenue from the sale of these diagnostic machines and associated services to healthcare organizations like Clalit and Sheba Medical Center.
NMTC
2nd
Neuroone Medical Technologies
$16.36 Mn
1.88
+0.00%
-62.25%
The company develops and sells diagnostic equipment, specifically the Evo Cortical and Evo sEEG electrodes used for intracranial monitoring in epilepsy diagnostics.
ASTC
2nd
Astrotech
$13.95 Mn
7.93
-2.82%
+56.10%
Through BreathTech Corporation, the company develops the BreathTest 1000 for disease screening via volatile organic compound metabolites, collaborating with clinical entities like the Cleveland Clinic Foundation.
ALRTF
ALR Technologies SG
$12.91 Mn
0.02
+0.00%
+100.00%
The company sells the 'Diabetes Solution' and 'GluCurve Pet CGM' products, which are FDA-cleared diagnostic systems that collect and analyze blood glucose data to provide clinical insights. These products are sold as diagnostic equipment and tests to healthcare providers, hospitals, and veterinary clinics.
ADVB
Advanced Biomed
$12.05 Mn
8.72
+5.95%
+3.81%
Advanced Biomed develops and sells medical testing equipment for cancer screening and diagnosis, specifically microfluidic biochips and devices like A+Pre and AC-1000. These products are sold to hospitals and clinical laboratories as diagnostic platforms and assays.
MBAI
Check-Cap
$8.38 Mn
8.36
+4.24%
+1,166.67%
Check-Cap develops the C Scan system, which consists of an ingestible X-ray emitting capsule (C Scan Cap) and a receiver (C Scan Track) used for clinical diagnostic imaging of the colon. The company sells the diagnostic machine and the associated software (C Scan View) to gastroenterology clinics and hospitals rather than performing the tests itself.
ADIL
2nd
Adial Pharmaceuticals
$8.23 Mn
5.45
+9.22%
-42.63%
The company develops and utilizes a companion diagnostic genetic test to identify patients likely to respond to its lead drug candidate, AD04.
TRIB
Trinity Biotech
$7.75 Mn
12.43
+11.28%
+691.72%
Trinity Biotech develops and manufactures clinical diagnostic equipment and tests, including rapid tests, enzyme linked immunosorbent assays, and molecular diagnostics platforms. It generates revenue from the sale of diagnostic kits, instruments, and reagents to hospitals and clinical laboratories.
LNAI
2nd
Lunai Bioworks
$6.75 Mn
2.16
-4.00%
-88.33%
The Renovaro Cube segment sells diagnostic test kits and provides an AI-driven platform for early cancer detection and recurrence monitoring, targeting hospitals and research centers.
FEMY
2nd
Femasys
$6.64 Mn
2.20
+1.85%
-84.29%
The company develops and sells diagnostic products used for clinical assessment, specifically FemVue for tubal assessment and FemChec for confirming tubal occlusion.
ACON
2nd
Aclarion
$6.40 Mn
2.60
-6.14%
-64.28%
The company provides the NOCISCAN MRS exam protocol and diagnostic technology used by imaging centers to perform clinical diagnostic tests for painful intervertebral discs. Its revenue is derived from payments from imaging centers and third-party payer reimbursements for these diagnostic exams.
CDIO
Cardio Diagnostics Holdings
$5.65 Mn
1.91
-4.02%
-48.66%
The company develops and sells clinical diagnostic tests such as Epi+Gen CHD and PrecisionCHD, which are used for the early detection and risk assessment of cardiovascular diseases. These products are sold as diagnostic assays to healthcare providers and health systems.
NDRA
ENDRA Life Sciences
$5.60 Mn
4.51
+0.45%
-6.43%
ENDRA develops the Thermo-Acoustic Enhanced Ultrasound (TAEUS) platform, which is a clinical diagnostic tool used to measure liver fat as a biomarker for metabolic diseases. The company sells the diagnostic capability via direct product sales, subscriptions, and licensing to OEMs, positioning it as a point-of-care alternative to MRI scans.
HSCS
HeartSciences
$5.59 Mn
2.13
-3.62%
-43.20%
HeartSciences develops and sells the MyoVista wav ECG device and AI ECG algorithms specifically for the clinical diagnosis of cardiac dysfunction and heart conditions. The company's revenue model is based on the sale of these diagnostic instruments and the recurring fees for the AI-driven diagnostic analysis.
BMRA
Biomerica
$4.73 Mn
1.56
+0.00%
-49.19%
Biomerica manufactures and sells diagnostic test kits, such as the hp detect and inFoods IBS tests, which analyze specimens to detect diseases and bacteria. These products are sold as diagnostic machines/tests to clinical laboratories and point-of-care settings, fitting the H-08 profile of selling the test rather than performing the service.
AIDX
2nd
20
$3.98 Mn
0.52
-5.45%
—
The company sells the BioCheck field test kit for screening suspicious powders for bioterror agents, which is a diagnostic test product sold to customers like fire departments.
VVOS
2nd
Vivos Therapeutics
$3.91 Mn
0.29
-3.33%
-93.48%
Vivos generates revenue from leasing SleepImage home sleep test recorders, which are diagnostic equipment used to identify sleep disorders.
AVCRF
Avricore Health
$3.04 Mn
0.03
+0.00%
-40.00%
Avricore Health sells the HealthTab point of care testing platform, which consists of analyzers and associated reagents for rapid blood analysis of biomarkers. Its revenue is generated from the sale, lease, or licensing of these diagnostic machines to pharmacy chains and independent pharmacists.
AMIX
2nd
Autonomix Medical
$2.63 Mn
6.17
-3.59%
-73.77%
The company's platform includes a diagnostic sensing component designed to identify disorder-related neuronal activity with high precision to enable targeted therapy. This diagnostic sensing capability is a core part of their development effort alongside the therapeutic ablation.
VNRX
Volitionrx
$2.17 Mn
0.47
-6.00%
-96.56%
VolitionRx manufactures and sells clinical diagnostic equipment and tests, specifically the Nu. Q® NETs assay for sepsis and the Nu. Q® Cancer assays for lung cancer. Revenue is generated from the sale of diagnostic kits and reagents to hospital laboratories and clinical institutions.
BJDX
Bluejay Diagnostics
$1.92 Mn
0.97
-4.90%
-82.55%
Bluejay Diagnostics develops the Symphony technology platform, which consists of a diagnostic analyzer and single-use protein detection cartridges for in vitro diagnostics. The company intends to generate revenue from the sale of these analyzers and the recurring sale of the assays/cartridges used to run the tests.
INBS
Intelligent Bio Solutions
$1.70 Mn
3.22
-4.45%
-78.53%
The company manufactures and sells the Intelligent Fingerprinting Drug Screening System, which consists of portable DSR Plus readers and single-use cartridges for point-of-care drug detection. This matches the description of in-vitro diagnostic analysers and point-of-care testing platforms.
ONCO
Onconetix
$1.68 Mn
0.75
-1.32%
-99.49%
Onconetix sells Proclarix, an in vitro diagnostic test for prostate cancer, to diagnostic laboratories, hospitals, and clinics. The company generates revenue from the sale of this diagnostic assay and its associated proprietary algorithm used to generate risk scores.
LUDG
2nd
Ludwig Enterprises
$1.67 Mn
0.01
-50.00%
-87.50%
The company sells at-home cheek swab collection kits, which are the physical diagnostic tools required to perform its proprietary mRNA-based tests.
VRAX
Virax Biolabs
$1.10 Mn
2.76
-1.78%
-85.90%
The company focuses on the detection and diagnosis of viral diseases through in vitro diagnostics, specifically developing the ViraxImmune brand for immune profiling tests and assays. It sells diagnostic test kits for respiratory infections, oncology, and cardiac markers to healthcare providers and laboratories.
WOK
2nd
WORK Medical Technology
$0.64 Mn
2.20
-5.58%
-100.00%
The company develops and sells diagnostic equipment, specifically the AI Automated Human Blood Cell Morphology Analyzer, and earns income from distribution agreements for this device.
ADTX
2nd
Aditxt
$0.00 Mn
0.00
—
-100.00%
Through its Pearsanta segment and Mitomic technology platform, the company develops mitochondrial DNA-based biomarkers and blood-based tests for the early detection of prostate cancer and endometriosis.